H2AX and prostate cancer: We screened 14,400 compounds in 480 mixtures of 30 compounds for the specific phenotype of increased γ-H2AX in DU-145 prostate cancer cells at 4 hours after drug therapy alone or in combination with 2 Gy of radiation.